Home

acțiune radiu tristeţe puma biotechnology inc Țipar chelnerul Monitor

Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com

Puma Biotechnology
Puma Biotechnology

Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive

Puma Biotechnology, Inc. 2020 Q3 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. 2020 Q3 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha

Puma Biotechnology, Inc. 2021 Q2 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. 2021 Q2 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha

PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence

Do Analysts Expect Puma Biotechnology Inc (PBYI) Stock to Rise After It Is Down -3.83% in a Month?
Do Analysts Expect Puma Biotechnology Inc (PBYI) Stock to Rise After It Is Down -3.83% in a Month?

Puma Biotechnology (PBYI) Company Information - Simply Wall St
Puma Biotechnology (PBYI) Company Information - Simply Wall St

Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters
Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters

Puma Biotechnology, Inc.Analytics - Traffic, Statistics and Competitor tracking | WatchMyCompetitor
Puma Biotechnology, Inc.Analytics - Traffic, Statistics and Competitor tracking | WatchMyCompetitor

Puma Biotechnology
Puma Biotechnology

Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer

Puma Biotechnology Reports Third Quarter 2021 Financial Results | Business Wire
Puma Biotechnology Reports Third Quarter 2021 Financial Results | Business Wire

Puma Biotechnology, Inc. (NASD:PBYI) Seasonal Chart | Equity Clock
Puma Biotechnology, Inc. (NASD:PBYI) Seasonal Chart | Equity Clock

Puma Biotechnology Inc (PBYI) Stock 5 Years History [Returns & Performance]
Puma Biotechnology Inc (PBYI) Stock 5 Years History [Returns & Performance]

Is Puma Biotechnology Inc. late reporting EU clinical trials?
Is Puma Biotechnology Inc. late reporting EU clinical trials?

Puma Biotechnology
Puma Biotechnology

With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq

With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq

Exhibitor Puma Biotechnology 07-10 - Scripps CME Connection
Exhibitor Puma Biotechnology 07-10 - Scripps CME Connection

Puma Biotechnology, Inc. (NASD:PBYI) Seasonal Chart | Equity Clock
Puma Biotechnology, Inc. (NASD:PBYI) Seasonal Chart | Equity Clock

Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology - Crunchbase Company Profile & Funding

Puma Biotechnology, Inc. 2020 Q3 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. 2020 Q3 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha

Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz

Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Profit Outlook
Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Profit Outlook

Puma Biotechnology's (PBYI) Highest Price: $275.07 (on 09-18-2014)
Puma Biotechnology's (PBYI) Highest Price: $275.07 (on 09-18-2014)

Articles with Puma Biotechnology
Articles with Puma Biotechnology